Riskpilot← Back to searchSign inGet full accessMedamza AB
ABActiveOrg 5593390544Kvarngatan 12General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
+13% vs 2024
Equity ratio
87.1%
Financial strength
Net profit 2025
SEK -5K
+9% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -5K | +13% |
| Net profit | SEK -5K | +9% |
| Total assets | SEK 31K | -46% |
| Equity | SEK 27K | -16% |
| Employees | 0 | — |
Legal name
Medamza AB
Org number
5593390544
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 oktober 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva uthyrning av läkare samt konsultverksamhet, informations- och utbildningsverksamhet inom medicin. Handel med värdepapper och därmed förenlig verksamhet.
Address
Kvarngatan 12
Email
amilie_moller@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | 55 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −4 | 46 | −6 | −5 |
| Depreciation & amort. | — | — | — | — |
| EBIT | −4 | 46 | −6 | −5 |
| Net financials | — | −1 | −0 | −0 |
| Profit before tax | −4 | 46 | −6 | −5 |
| Tax | — | −9 | — | — |
| Net profit | −4 | 37 | −6 | −5 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 24 | 73 | 57 | 31 |
| Equity | 21 | 58 | 32 | 27 |
| Long-term debt | — | — | — | — |
| Short-term debt | 3 | 15 | 25 | 4 |
| Total debt | 3 | 15 | 25 | 4 |
EBITDA margin
-490100.0%
This company
15.8%
Market median
-3101999% vs market
20222025
Equity ratio
87.1%
This company
38.2%
Market median
+128% vs market
20222025
Return on equity
-19.3%
This company
18.4%
Market median
-205% vs market
20222025
Net profit margin
-520900.0%
This company
8.1%
Market median
-6430964% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-06 – 2022-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medamza AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristina Olofsdotter Ängeby Möller | Board of Directors | 0 companies |
| Amilie Charlotte Möller | Board of Directors | 0 companies |